Archives
-
CSBTA Pharmacokinetics in MASH Mice
2026-09-21
The reference study integrates pharmacokinetics, tissue distribution, transporter biology, and metabolic-enzyme profiling to explain how MASH alters exposure to Corydalis saxicola Bunting total alkaloids. Its findings indicate that disease state and repeated dosing can increase systemic and hepatic accumulation of dehydrocavidine, palmatine, and berberine, with implications for exposure-guided treatment design.
-
From Reporter mRNA to Translational Readiness
2026-09-20
Synthetic reporter mRNA is more than a fluorescence reagent: it is a controlled system for separating delivery, translation, stability, and innate immune effects. This article explains how EZ Cap™ EGFP mRNA (5-moUTP) can strengthen translational workflows and how its mechanistic design informs more ambitious mRNA delivery programs.
-
Bradykinin Assay Design: From Signal to Mechanism
2026-09-19
Bradykinin is more than an endothelium-dependent vasodilator: it is a strategic perturbation tool for separating vascular tone, permeability, smooth muscle, pain, and inflammatory readouts. This guide combines assay architecture with lessons from a recent mechanistic study to improve causal interpretation and reproducibility.
-
3-Deazaadenosine: From Methylation to Translation
2026-09-18
A translational perspective on 3-Deazaadenosine as an S-adenosylhomocysteine hydrolase inhibitor, linking methylation biology, ulcerative colitis research, and preclinical antiviral strategy. The article explains how to use the compound as a mechanistic probe while separating pharmacological methylation pressure from gene-specific perturbation.
-
Nadolol (SQ-11725) Research Workflows
2026-09-18
Nadolol (SQ-11725) supports controlled beta-adrenergic blockade in cardiovascular assays while also enabling transporter-aware pharmacokinetic experiments. This practical guide combines receptor signaling workflows with lessons from a 2025 tissue-distribution study to improve dosing, sampling, and troubleshooting.
-
Cell and Reporter Choice in mRNA-LNP Assays
2026-09-17
Zhen et al. show that cell-line and reporter selection can substantially change apparent mRNA-LNP transfection efficiency, dose response, and assay reproducibility. HEK 293T cells and eGFP produced the most consistent in-vitro measurements, whereas luciferase performance varied by cell type and among technical replicates.
-
ARCA EGFP mRNA (5-moUTP) Workflow Guide
2026-09-17
ARCA EGFP mRNA (5-moUTP) provides a direct, fluorescence-based readout for delivery and translation in mammalian cells without requiring plasmid transcription. Its ARCA cap, 5-moUTP chemistry, and optimized poly(A) tail support consistent reporter performance while disciplined cold-chain handling improves assay reproducibility.
-
Vacuolin-1: Lysosomal Exocytosis Inhibitor
2026-09-16
Vacuolin-1 is a cell-permeable lysosomal exocytosis inhibitor that blocks Ca2+-dependent lysosome–plasma membrane fusion. Its selective activity supports β-hexosaminidase release assays, membrane-repair studies, and mechanistic analysis of lysosome-mediated membrane trafficking.
-
FerroOrange for Live-Cell Fe²⁺ Detection
2026-09-15
FerroOrange is a live-cell Fe²⁺ fluorescent probe for connecting intracellular iron detection with microscopy, flow cytometry, and plate-based assays. This workflow guide translates the Cdk5–AMPK ferroptosis findings in ischemic injury into practical assay design, controls, and troubleshooting decisions.
-
REV1–DHX36 Coordinates G-Quadruplex Tolerance
2026-09-15
The reference study identifies a direct REV1–DHX36 interaction that coordinates G-quadruplex unwinding, replication-fork progression, and suppression of single-stranded DNA gaps. Its findings establish REV1 as more than a translesion polymerase scaffold: it also regulates helicase activity and cellular tolerance of stabilized G-quadruplex DNA.
-
40 Hz GENUS Limits Epileptogenesis via the dLGN Shell
2026-09-14
Wang and colleagues show that chronic 40 Hz light flicker reduces epileptogenesis-related pathology and seizure susceptibility in a pilocarpine status epilepticus mouse model. The study further identifies a retina–dorsal lateral geniculate nucleus shell–visual cortex pathway that links sensory gamma entrainment to parvalbumin-interneuron activity.
-
Golgi-Tracker Green in Translational Oncology
2026-09-14
A mechanistic and strategic guide to using Golgi-Tracker Green for live-cell Golgi imaging, lipid trafficking studies, and translational investigation of Golgi stress in hormone receptor-positive breast cancer.
-
Troxerutin Targets TRPM7 in Diabetic Cognitive Dysfunction
2026-09-13
This study identifies a TRPM7–calcineurin–Drp1Ser637 axis that links calcium dysregulation to mitochondrial fission, neuronal apoptosis, and diabetic cognitive dysfunction. Using db/db mice and high-glucose HT22 neurons, the authors show that troxerutin improves cognitive and mitochondrial outcomes by suppressing this pathway, while also defining important limits for translation beyond the experimental models.
-
DAPI in Microbiome-Driven Cancer Research
2026-09-12
The Prevotella copri–IPyA–UHRF1–AMPK axis illustrates why translational researchers need both mechanistic assays and disciplined phenotypic quality control. This article explains how DAPI and 4',6-Diamidino-2-Phenylindole can support nuclear visualization, apoptosis-oriented analysis, viability assessment, and flow cytometry without being mistaken for a pathway-specific biomarker.
-
o-Agatoxin IVA and Excitotoxicity in Cortical Neurons
2026-09-11
The 1996 study by Lustig, Ahern, and Greenberg tested whether o-Agatoxin IVA could protect cultured cortical neurons from excitotoxic injury triggered by veratridine, ouabain, or NMDA. Its central finding was that blocking P/Q- and Q-type calcium channels did not reduce LDH-defined neuronal toxicity, emphasizing that inhibition of glutamate release is not necessarily sufficient for neuroprotection.